LT3313408T - Kontraceptikas drospirenono pagrindu, skirtas pacientėms, turinčioms antsvorio - Google Patents

Kontraceptikas drospirenono pagrindu, skirtas pacientėms, turinčioms antsvorio

Info

Publication number
LT3313408T
LT3313408T LTEPPCT/EP2016/064574T LTEP2016064574T LT3313408T LT 3313408 T LT3313408 T LT 3313408T LT EP2016064574 T LTEP2016064574 T LT EP2016064574T LT 3313408 T LT3313408 T LT 3313408T
Authority
LT
Lithuania
Prior art keywords
drospirenone
overweight patients
based contraceptive
contraceptive
overweight
Prior art date
Application number
LTEPPCT/EP2016/064574T
Other languages
English (en)
Lithuanian (lt)
Inventor
Dominique Drouin
Cécile BOYER-JOUBERT
Philippe Perrin
Original Assignee
Laboratorios Leon Farma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=56178376&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LT3313408(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from CN201510348953.1A external-priority patent/CN106265694A/zh
Priority claimed from EP15305965.4A external-priority patent/EP3108889A1/en
Application filed by Laboratorios Leon Farma Sa filed Critical Laboratorios Leon Farma Sa
Publication of LT3313408T publication Critical patent/LT3313408T/lt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
LTEPPCT/EP2016/064574T 2015-06-23 2016-06-23 Kontraceptikas drospirenono pagrindu, skirtas pacientėms, turinčioms antsvorio LT3313408T (lt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN201510348953.1A CN106265694A (zh) 2015-06-23 2015-06-23 用于过重女性患者的基于屈螺酮的避孕药
EP15305965.4A EP3108889A1 (en) 2015-06-23 2015-06-23 Drospirenone-based contraceptive for a female patient affected with excess weight
PCT/EP2016/064574 WO2016207298A1 (en) 2015-06-23 2016-06-23 Drospirenone-based contraceptive for a female patient affected with excess weight

Publications (1)

Publication Number Publication Date
LT3313408T true LT3313408T (lt) 2024-03-12

Family

ID=56178376

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEPPCT/EP2016/064574T LT3313408T (lt) 2015-06-23 2016-06-23 Kontraceptikas drospirenono pagrindu, skirtas pacientėms, turinčioms antsvorio

Country Status (26)

Country Link
EP (1) EP3313408B1 (enExample)
JP (1) JP6827962B2 (enExample)
KR (1) KR102217942B1 (enExample)
CN (2) CN108025014B (enExample)
AU (1) AU2016282863B2 (enExample)
BR (1) BR112017028048A2 (enExample)
CA (1) CA2989975C (enExample)
DK (1) DK3313408T3 (enExample)
EA (1) EA036497B1 (enExample)
ES (1) ES2970532T3 (enExample)
FI (1) FI3313408T3 (enExample)
HR (1) HRP20240121T8 (enExample)
HU (1) HUE065350T2 (enExample)
LT (1) LT3313408T (enExample)
MX (1) MX389310B (enExample)
MY (1) MY187233A (enExample)
NI (1) NI201700173A (enExample)
PH (1) PH12017502379A1 (enExample)
PL (1) PL3313408T3 (enExample)
RS (1) RS65196B1 (enExample)
SI (1) SI3313408T1 (enExample)
SM (1) SMT202400062T1 (enExample)
SV (1) SV2017005602A (enExample)
UA (1) UA122873C2 (enExample)
WO (1) WO2016207298A1 (enExample)
ZA (1) ZA201800067B (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2383279A1 (en) 2011-07-19 2011-11-02 Pantarhei Bioscience B.V. Process for the preparation of estetrol
MY195019A (en) 2015-06-18 2023-01-03 Estetra Sprl Orodispersible dosage unit containing an estetrol component
MD3310346T2 (ro) 2015-06-18 2021-06-30 Estetra Sprl Comprimată orodispersabilă ce conține estetrol
JP6866560B2 (ja) 2015-06-18 2021-04-28 エステトラ ソシエテ プリーヴ ア レスポンサビリテ リミテ エステトロール成分を含有する口腔内崩壊性投与単位
HUE054589T2 (hu) 2015-06-18 2021-09-28 Estetra Sprl Szájban diszpergálódó esztetrol tartalmú tabletta
MX389310B (es) 2015-06-23 2025-03-20 Laboratorios Leon Farma Sa Anticonceptivos a base de drospirenona para paciente femenina afectada con exceso de peso.
KR102712911B1 (ko) 2016-08-05 2024-10-04 에스테트라, 소시에떼 아 레스폰서빌리떼 리미떼 월경통 및 생리통의 관리방법
JOP20200260A1 (ar) 2018-04-19 2019-10-19 Estetra Sprl مركبات واستخداماتها للتخفيف من الأعراض المصاحبة لانقطاع الطمث
TWI801561B (zh) 2018-04-19 2023-05-11 比利時商依思特拉私人有限責任公司 化合物及其用於緩解絕經相關症狀的用途
TWI893101B (zh) 2020-04-16 2025-08-11 比利時商埃斯特拉有限責任公司 具有降低之副作用之避孕組成物
EP4134082A1 (en) 2021-08-12 2023-02-15 Chemo Research, S.L. Method for treating endometriosis and providing effective contraception

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2652761C2 (de) 1976-11-16 1985-11-21 Schering AG, 1000 Berlin und 4709 Bergkamen 15,16-Methylen-Spirolactone, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE19525017A1 (de) * 1995-06-28 1997-01-02 Schering Ag Pharmazeutisches Kombinatonspräparat, Kit und Methode zur hormonalen Kontrazeption
DE19633685C1 (de) 1996-08-12 1997-10-09 Schering Ag Verfahren zur Herstellung von Drospirenon (6beta,7beta;15 beta,16beta-Dimethyl-en-3-oxo-17alpha-pregn-4-en-21,17-carbolacton, DRSP) sowie 7alpha-(3-Hydroxy-1-propyl)-6beta,7beta;15beta, 16beta-dimethylen-5beta-androstan-3beta,5,17beta-triol (ZK 92836) und 6beta,7beta;15beta,16beta-dimethylen-5beta-hydroxy-3-oxo-17alpha-androstan-21,17-carbolacton (90965) als Zwischenprodukte des Verfahrens
WO2004041288A1 (en) * 2002-11-05 2004-05-21 Schering Aktiengesellschaft Hormone replacement therapy with drospirenone
CN107875388A (zh) * 2004-04-30 2018-04-06 拜耳知识产权有限责任公司 对延长的激素避孕方案中突破性出血的控制
MY151322A (en) * 2004-04-30 2014-05-15 Bayer Ip Gmbh Management of breakthrough bleeding in extended hormonal contraceptive regimens
EP1773344A1 (en) * 2004-07-07 2007-04-18 Wyeth a Corporation of the State of Delaware Cyclic progestin regimens and kits
ITMI20042338A1 (it) 2004-12-06 2005-03-06 Ind Chimica Srl Processo per la preparazione di drospirenone
ATE403668T1 (de) 2005-07-21 2008-08-15 Bayer Schering Pharma Ag Verfahren zur herstellung von 3-oxo-pregn-4-en-21,17-carbolactonen durch die metallfreie oxidation von 17-(3-hydroxypropyl)-3,17- dihydroxyandrostanen
MX2009010763A (es) * 2007-04-05 2009-10-28 Bayer Schering Pharma Ag NUEVO REGIMEN DE DROSPIRENONA/17ß-ESTRADIOL, PRODUCTO FARMACEUTICO COMBINADO Y CONJUNTO DE ELEMENTOS (KIT) PARA SU APLICACION.
EP2548881B1 (en) * 2010-03-16 2014-12-17 Taizhou Taifa Pharmaceuticals Co., Ltd Preparation method of drospirenone
RU2422824C1 (ru) * 2010-05-07 2011-06-27 Федеральное Государственное Учреждение Ростовский научно-исследовательский институт акушерства и педиатрии Федерального агентства по высокотехнологичной медицинской помощи Способ выбора тактики лечения нарушений менструального цикла у девочек-подростков с избыточной массой тела
US9375437B2 (en) * 2010-06-18 2016-06-28 Lipocine Inc. Progesterone containing oral dosage forms and kits
AR081670A1 (es) * 2010-06-29 2012-10-10 Leon Farma Sa Lab Composicion farmaceutica que comprende drospirenona y kit anticonceptivo
CN103372015A (zh) * 2012-04-19 2013-10-30 国家人口计生委科学技术研究所 包含屈螺酮或屈螺酮和雌激素的阴道环制剂
RU2527357C1 (ru) * 2013-08-02 2014-08-27 Государственное бюджетное образовательное Учреждение высшего профессионального образования "Московский государственный медико-стоматологический университет имени А.И. Евдокимова" Министерства здравоохранения Российской Федерации (МГМСУ имени А.И. Евдокимова" Минздрава России) Способ персонифицированной профилактики эстрогензависимых заболеваний у здоровых женщин и женщин с факторами сердечно-сосудистого риска в возрасте 45-60 лет
MX389310B (es) 2015-06-23 2025-03-20 Laboratorios Leon Farma Sa Anticonceptivos a base de drospirenona para paciente femenina afectada con exceso de peso.

Also Published As

Publication number Publication date
SV2017005602A (es) 2018-08-14
KR102217942B1 (ko) 2021-02-19
WO2016207298A1 (en) 2016-12-29
CN113750108B (zh) 2025-08-19
EA201792595A1 (ru) 2018-06-29
CN108025014A (zh) 2018-05-11
EP3313408B1 (en) 2023-12-06
ES2970532T3 (es) 2024-05-29
UA122873C2 (uk) 2021-01-13
HUE065350T2 (hu) 2024-05-28
HRP20240121T1 (hr) 2024-04-12
DK3313408T3 (da) 2024-01-29
PH12017502379A1 (en) 2018-06-25
AU2016282863B2 (en) 2021-05-27
AU2016282863A1 (en) 2018-02-08
SI3313408T1 (sl) 2024-04-30
MX389310B (es) 2025-03-20
BR112017028048A2 (pt) 2018-09-04
NI201700173A (es) 2018-04-02
JP2018527305A (ja) 2018-09-20
SMT202400062T1 (it) 2024-03-13
CN108025014B (zh) 2021-10-22
MX2017016801A (es) 2018-05-11
JP6827962B2 (ja) 2021-02-10
CN113750108A (zh) 2021-12-07
EP3313408A1 (en) 2018-05-02
FI3313408T3 (fi) 2024-01-25
HRP20240121T8 (hr) 2024-05-10
PL3313408T3 (pl) 2024-04-15
NZ739195A (en) 2024-04-26
RS65196B1 (sr) 2024-03-29
CA2989975A1 (en) 2016-12-29
EA036497B1 (ru) 2020-11-17
CA2989975C (en) 2021-10-12
ZA201800067B (en) 2019-07-31
HK1255216A1 (zh) 2019-08-09
KR20180019173A (ko) 2018-02-23
MY187233A (en) 2021-09-13

Similar Documents

Publication Publication Date Title
LT3313408T (lt) Kontraceptikas drospirenono pagrindu, skirtas pacientėms, turinčioms antsvorio
EP4129249C0 (en) OSTOMY APPARATUS
EP3490474A4 (en) ORTHOPEDIC TIED IMPLANTS AND SYSTEM
EP3344318A4 (en) Patient interfaces
HUE049935T2 (hu) Osztómiás készülék
DK3280368T3 (da) Stomianordning
DK3265421T3 (da) Doseringssystem
EP3352719A4 (en) WHEELCHAIR WITH MOBILITY IMPROVEMENT
DK3186475T3 (da) Trådløst brøndoverførselssystem
LT3390390T (lt) Bipirazolilo dariniai, tinkami naudoti autoimuninių ligų gydymui
DK3705102T3 (da) Patientløftesystem
EP3603642A4 (en) PHARMACEUTICAL PREPARATION
EP3300502A4 (en) PROCESS FOR PREPARING VITAMIN A OLIGOSACCHARIDES AND METHOD FOR THE PRODUCTION THEREOF
EP3380049C0 (en) PROSTHESIS FOR PATIENTS WITH ENTEROSTOMY
EP3246047C0 (en) COMBINATION MEDICATION
PL3390450T3 (pl) Humanizowane przeciwciało anty-cd28 formułowane do podawania ludziom
EP3373875A4 (en) BANDAGE
DK3166473T3 (da) Oftalmoskoper
EP3756626C0 (en) ASTRAGALOCALCANEAN JOINT IMPLANT
DK2932944T3 (da) Støtteortose
EP3646866A4 (en) PHARMACEUTICAL PREPARATION
EP3373871C0 (de) Uterotubar-implantat-vorrichtung
DK3325027T3 (da) Medicinsk implantat
HUE069648T2 (hu) Gyógyszerészeti készítmény
DK3116517T3 (da) Vaginal, mucoadhæsiv tablet med forlænget frigivelse